Company intelligence / Profile preview

Coridea

New York, New York, USA

Ownership: Private
Development stage: Other

Overview

Coridea is a medical device incubator with a focus on developing novel solutions for cardio, pulmonary, and renal diseases. It has launched over 15 companies, including Ardian (acquired by Medtronic), Evalve (acquired by Abbott), CHF Solutions, and Respicardia, which have collectively returned over $1.6 billion to investors. The company’s strategy is to identify unmet clinical needs, rapidly prototype solutions, and advance them through development to commercial launch or acquisition.

Therapeutic areas: NephrologyCardiovascularPulmonology
Modalities: Device
Industry: Investors

Partnerships

Deerfield Management: Deerfield Device Design and Development Catalyst (Deerfield Catalyst)

Beyond the preview

Go deeper on Coridea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coridea.

Explore the full profile